AstraZeneca said on Friday it will spend $2.5 billion on a research and development hub in Beijing, as the drugmaker ...

Cambridge-headquartered AstraZeneca is investing $2.5 billion in Beijing to establish its sixth global strategic R & D centre ...

Multinational pharmaceutical company AstraZeneca is bullish about China's role as a global innovation powerhouse, underpinned ...

This is the latest sign of global healthcare giants doubling down on the market in recent years. Experts noted on Monday that ...

BEIJING] AstraZeneca will invest US$2.5 billion in a new research centre in Beijing, in a major show of commitment to China ...

HONG KONG, LONDON] Ever since AstraZeneca shocked investors in October with news its China chief was under investigation, the ...

Chief Executive Officer Pascal Soriot has frequently talked up the scientific promise of China. Friday’s announcement came as he met Beijing’s Mayor Yin Yong, who according to Chinese media ...

British pharmaceutical giant AstraZeneca announced on Friday that it will invest $2.5 billion in a research and development ...

They include Rajesh Subramaniam of FedEx, Bill Winters of Standard Chartered, Paul Hudson of Sanofi, and Pascal Soriot of ...

China encourages deep engagement in the domestic market and looks forward to sharing development benefits, Han Wenxiu, ...

Beijing: AstraZeneca has announced an investment of USD 2.5 billion in Beijing to establish its sixth global strategic R&D ...

Chief Executive Pascal Soriot was in Beijing and met with the city's mayor to reveal the investment, along with two licensing deals with Chinese companies, and a joint venture with a third Chinese ...